TIL compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

TILInstil Bio, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

TILInstil Bio, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

TILInstil Bio, Inc.

6.58▲+0.46%· post 6.68· delayed

Mkt cap$46.1MRevenue—Revenue—

AMGNAmgen Inc

460.67▼−1.03%· post 453.11· delayed

After hoursNov 3 '26delayed

Mkt cap$251.6BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

After hoursNov 3 '26delayed

TILInstil Bio, Inc.

AMGNAmgen Inc

6.58▲+0.46%post 6.68delayed

Price

460.67▼−1.03%post 453.11delayed

$46.1M

Mkt cap

$251.6B

—

Revenue

$10.1BQ2 FY26

—

Revenue

$36.8BFY25

TIL6.58▲+0.46%vsAMGN460.67▼−1.03%After hoursNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

TIL: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TIL 2

AZNAstraZeneca Pharmaceuticalscustomer

—ImmuneOnco Biopharmaceuticals (Shanghai)unlistedsupplier

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

Price

rebased to 0%

TIL, solidAMGN, dashed